Nurix Therapeutics, Inc. financial data

Symbol
NRIX on Nasdaq
Location
Brisbane, CA
Fiscal year end
30 November
Latest financial report
10-Q - Q3 2025 - 09 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 622 % +46.3%
Debt-to-equity 31.2 % -39.5%
Return On Equity -53.6 % +15.5%
Return On Assets -40.8 % +2.37%
Operating Margin -195 % +55.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 76.9M shares +8.54%
Common Stock, Shares, Outstanding 76.9M shares +14.6%
Entity Public Float 996M USD +112%
Common Stock, Value, Issued 77K USD +14.9%
Weighted Average Number of Shares Outstanding, Basic 84.2M shares +15.6%
Weighted Average Number of Shares Outstanding, Diluted 84.2M shares +15.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 80.9M USD +94%
Revenue from Contract with Customer, Excluding Assessed Tax 83.7M USD -37.3%
Research and Development Expense 301M USD +47.5%
General and Administrative Expense 49.8M USD +8.27%
Operating Income (Loss) -267M USD -38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -244M USD -38.1%
Income Tax Expense (Benefit) 768K USD +193%
Net Income (Loss) Attributable to Parent -245M USD -38.3%
Earnings Per Share, Basic -2 USD/shares -1.72%
Earnings Per Share, Diluted -2 USD/shares -1.72%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 78.4M USD -20.8%
Marketable Securities, Current 217M USD -27.1%
Cash, Cash Equivalents, and Short-term Investments 429M USD -4.31%
Accounts Receivable, after Allowance for Credit Loss, Current 19M USD
Assets, Current 441M USD -3.39%
Property, Plant and Equipment, Net 20.5M USD +20.1%
Operating Lease, Right-of-Use Asset 53M USD +95.8%
Other Assets, Noncurrent 7.38M USD +143%
Assets 522M USD +1.73%
Accounts Payable, Current 8.61M USD +120%
Employee-related Liabilities, Current 16.4M USD +39.9%
Contract with Customer, Liability, Current 26M USD -45.8%
Liabilities, Current 82.4M USD -4.57%
Contract with Customer, Liability, Noncurrent 15.2M USD -49.2%
Operating Lease, Liability, Noncurrent 52.7M USD +156%
Liabilities 150M USD +9.86%
Accumulated Other Comprehensive Income (Loss), Net of Tax 119K USD -65.4%
Retained Earnings (Accumulated Deficit) -925M USD -36%
Stockholders' Equity Attributable to Parent 372M USD -1.22%
Liabilities and Equity 522M USD +1.73%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -61.1M USD -45.6%
Net Cash Provided by (Used in) Financing Activities 1.47M USD -9.3%
Net Cash Provided by (Used in) Investing Activities 25.5M USD -28.1%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 76.9M shares +14.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -34.1M USD -608%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 79.4M USD -20.6%
Deferred Tax Assets, Valuation Allowance 227M USD +17.2%
Deferred Tax Assets, Gross 233M USD +15%
Operating Lease, Liability 28.3M USD -7.55%
Payments to Acquire Property, Plant, and Equipment 3.49M USD +20.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -245M USD -39.7%
Lessee, Operating Lease, Liability, to be Paid 38.5M USD -9.41%
Property, Plant and Equipment, Gross 61.2M USD +24.5%
Operating Lease, Liability, Current 3.79M USD -42.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.91M USD -36.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.24M USD +7.77%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.1M USD -14.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.99M USD +2.71%
Deferred Tax Assets, Operating Loss Carryforwards 91.8M USD -0.37%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 21.9M USD +41%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.07M USD +2.71%
Operating Lease, Payments 2.15M USD +12.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 6.09M USD -31.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%